Man Group’s Array Biopharma Inc ARRY Stock Holding History

Man Group’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-680,000	Closed	-$31.5M	–	2029
2019 Q2	$31.5M	Buy	680,000 +664,187	+4,200%	+$18.6M	0.11%	211
2019 Q1	$386K	Buy	+15,813	New	+$329K	﹤0.01%	1765
2018 Q4	–	Sell	-124,329	Closed	-$1.89M	–	2233
2018 Q3	$1.89M	Buy	+124,329	New	+$1.91M	0.01%	1447

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Man Group's ARRY Position: Q3 2019 in Review

Man Group sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 680,000 shares — an estimated $31.5M sold.

Man Group first reported a position in ARRY in Q3 2018 and held it in 3 quarters. The position peaked at $31.5M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Man Group reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Man Group sold 680,000 Array Biopharma Inc shares in Q3 2019, an estimated $31.5M.
Man Group first reported a position in Array Biopharma Inc in Q3 2018 and held it in 3 quarters.
Man Group's Array Biopharma Inc position peaked at $31.5M in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Man Group's 13F filing for Q3 2019, filed 14 Nov 2019.